Sarah Joanne Bucknell (Sarah J Bucknell)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 2

Top Topics

Extracorporeal Membrane Oxygenation

Combination Therapy

Transcription Factor

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Simon Poulter, Nigel Austin, Rachel Armstrong, Matt Barnes, Sarah Joanne Bucknell, Alicia Higueruelo, Joydeep Banerjee, Andy Mead, Richard Mould, Cliona MacSweeney, M Alistair O'Brien, Lisa Alice Stott, Stephen P Watson
The Identification of GPR52 Agonist HTL0041178, a Potential Therapy for Schizophrenia and Related Psychiatric Disorders. ACS medicinal chemistry letters 14 (4) (2023)
Sarah Joanne Bucknell, Mark A Ator, Alastair J H Brown, Jason Brown, Andrew D Cansfield, Julie E Cansfield, John A Christopher, Miles Congreve, Gabriella Cseke, Francesca Deflorian, Christopher R Jones, Jonathan S Mason, M Alistair O'Brien, Gregory R Ott, Mark Pickworth, Stacey M Southall
Structure-Based Drug Discovery of N-((R)-3-(7-Methyl-1H-indazol-5-yl)-1-oxo-1-(((S)-1-oxo-3-(piperidin-4-yl)-1-(4-(pyridin-4-yl)piperazin-1-yl)propan-2-yl)amino)propan-2-yl)-2'-oxo-1',2'-dihydrospiro[piperidine-4,4'-pyrido[2,3-d][1,3]oxazine]-1-carboxamide (HTL22562): A Calcitonin Gene-Related Peptide Receptor Antagonist for Acute Treatment of Migraine. Journal of medicinal chemistry 63 (14) (2020)